Acquisition Synergy Team Technologies acquired TAG3 Engineering, signaling post‑deal integration of design and manufacturing capabilities. This creates opportunities to partner with Team Technologies and its customers for ongoing medtech design work, pre‑production validation, and regulatory readiness.

End-to-End Capabilities TAG3 offers an end-to-end medtech design and development suite covering concept generation, prototyping, process development, verification and validation, sterilization validation, risk assessment, design controls, IP documentation, and regulatory remediation. This makes TAG3 attractive to medtech startups and SMEs seeking a single partner to shorten time-to-market and simplify vendor management.

Regulatory Readiness Robust regulatory remediation, design controls management, risk assessment, sterilization validation, preclinical testing, and IP support address customers facing stringent compliance requirements and post-market obligations, enabling sales to risk-averse manufacturers and those pursuing faster regulatory approvals.

SMB Engagement Model Lean team enables flexible, cost-efficient engagement models—project-based, retainers, or sprint work—tailored to medtech startups and mid-market firms.

Regional Market Advantage Based in Fort Lauderdale, TAG3 sits in the Southeast medtech cluster, offering potential to partner with regional hospitals, universities, and accelerators for early-stage design, prototyping, and validation collaborations, and to accelerate regional deals.